<DOC>
	<DOC>NCT01919866</DOC>
	<brief_summary>Feasibility and toxicity of haploidentical transplantation of CD3/CD19 depleted stem cells in combination with a toxicity reduced conditioning regimen or with standard conditioning regimens according to underlying disease.</brief_summary>
	<brief_title>Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Anemia, Aplastic</mesh_term>
	<criteria>patients with primary refractory or relapsed disease (including relapse after previous SCT and active disease) AML in complete remission of refractory MDS RAEBt/secondary AML ALL CML NonHodgkin Lymphoma / Hodgkin Lymphoma non malignant diseases (aplastic anemia, thalassemia, SCID) relapsed Neuroblastoma relapsed soft tissue sarcoma (Rhabdomyosarcoma, Ewing sarcoma, PNET soft tissue sarcoma with primary bone metastases or bone marrow in whom no matched donor was available, &lt; 6 months after previous HSCT active cerebral seizure conditions massive progression of leukemias or solid tumours before planned trp. left ventricular ejection fraction &lt;25% creatinine clearance &lt;40ml/min before conditioning respiratory insufficiency with oxygen demand or DLCO &lt;30% Bilirubin &gt;4mg/dl, GOT/GPT &gt;400 severe infection (HIV, Aspergillosis) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>